Correlation Between Newron Pharmaceuticals and COSMO Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Newron Pharmaceuticals and COSMO Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newron Pharmaceuticals and COSMO Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Newron Pharmaceuticals SpA and COSMO Pharmaceuticals SA, you can compare the effects of market volatilities on Newron Pharmaceuticals and COSMO Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newron Pharmaceuticals with a short position of COSMO Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newron Pharmaceuticals and COSMO Pharmaceuticals.

Diversification Opportunities for Newron Pharmaceuticals and COSMO Pharmaceuticals

0.11

Correlation Coefficient

Newron Pharmaceuticals  COSMO Pharmaceuticals

Average diversification

The 3 months correlation between Newron and COSMO is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Newron Pharmaceuticals SpA and COSMO Pharmaceuticals SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSMO Pharmaceuticals and Newron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newron Pharmaceuticals SpA are associated (or correlated) with COSMO Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSMO Pharmaceuticals has no effect on the direction of Newron Pharmaceuticals i.e., Newron Pharmaceuticals and COSMO Pharmaceuticals go up and down completely randomly.

Pair Corralation between Newron Pharmaceuticals and COSMO Pharmaceuticals

Assuming the 90 days trading horizon Newron Pharmaceuticals SpA is expected to generate 3.54 times more return on investment than COSMO Pharmaceuticals. However, Newron Pharmaceuticals is 3.54 times more volatile than COSMO Pharmaceuticals SA. It trades about 0.01 of its potential returns per unit of risk. COSMO Pharmaceuticals SA is currently generating about -0.26 per unit of risk. If you would invest  857.00  in Newron Pharmaceuticals SpA on September 27, 2024 and sell it today you would lose (8.00) from holding Newron Pharmaceuticals SpA or give up 0.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Newron Pharmaceuticals SpA  vs.  COSMO Pharmaceuticals SA

Newron Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Newron Pharmaceuticals SpA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Newron Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

COSMO Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days COSMO Pharmaceuticals SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Newron Pharmaceuticals and COSMO Pharmaceuticals

The main advantage of trading using opposite Newron Pharmaceuticals and COSMO Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newron Pharmaceuticals position performs unexpectedly, COSMO Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSMO Pharmaceuticals will offset losses from the drop in COSMO Pharmaceuticals' long position.

The idea behind Newron Pharmaceuticals SpA and COSMO Pharmaceuticals SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.